Mesalamine

Announcement

You can now add alternative names! Click here to add other names that you've published under.

"Mesalamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)

Descriptor ID	D019804
MeSH Number(s)	D02.241.223.100.050.300.500 D02.241.223.100.300.595.100.540 D02.241.511.390.595.100.540 D02.455.426.559.389.127.020.452.750 D02.455.426.559.389.127.281.595.100.540 D02.455.426.559.389.657.410.595.100.540
Concept/Terms	Mesalamine Mesalamine m-Aminosalicylic Acid m Aminosalicylic Acid 5-Aminosalicylic Acid 5 Aminosalicylic Acid Mesalazine meta-Aminosalicylic Acid meta Aminosalicylic Acid Asacolon Asacolon Celltech Brand of Mesalamine Ascolitin Ascolitin Sanofi Synthelabo Brand of Mesalamine Henning Berlin Brand of Mesalamine Canasa Canasa Salofalk Provalis Brand of Mesalamine Falk Brand of Mesalamine Farmasa Brand of Mesalamine Axcan Brand of Mesalamine Antigen Brand of Mesalamine Claversal Claversal SmithKline Brand of Mesalamine Merckle Brand of Mesalamine Fivasa Fivasa Norgine Brand of Mesalamine Lixacol Lixacol Schering-Plough Brand of Mesalamine Schering Plough Brand of Mesalamine Mesalamine Hydrochloride Mesalamine Hydrochloride Hydrochloride, Mesalamine Mesalamine Monosodium Salt Mesalamine Monosodium Salt Monosodium Salt, Mesalamine Mesasal Mesasal GlaxoSmithKline Brand of Mesalamine Novo-5 ASA Novo-5 ASA Novo 5 ASA Novo5 ASA Novopharm Brand of Mesalamine Pentasa Pentasa Ferring Brand of Mesalamine Yamanouchi Brand of Mesalamine Allphar Brand of Mesalamine Rowasa Rowasa Solvay Brand of Mesalamine 5-Aminosalicylate 5-Aminosalicylate 5 Aminosalicylate Asacol Asacol Procter & Gamble Brand of Mesalamine Byk Brand of Mesalamine

Below are MeSH descriptors whose meaning is more general than "Mesalamine".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Carboxylic Acids [D02.241]
Acids, Carbocyclic [D02.241.223]
Benzoates [D02.241.223.100]
Aminobenzoates [D02.241.223.100.050]
meta-Aminobenzoates [D02.241.223.100.050.300]
Mesalamine [D02.241.223.100.050.300.500]
Hydroxybenzoates [D02.241.223.100.300]
Salicylates [D02.241.223.100.300.595]
Aminosalicylic Acids [D02.241.223.100.300.595.100]
Mesalamine [D02.241.223.100.300.595.100.540]
Hydroxy Acids [D02.241.511]
Hydroxybenzoates [D02.241.511.390]
Salicylates [D02.241.511.390.595]
Aminosalicylic Acids [D02.241.511.390.595.100]
Mesalamine [D02.241.511.390.595.100.540]
Hydrocarbons [D02.455]
Hydrocarbons, Cyclic [D02.455.426]
Hydrocarbons, Aromatic [D02.455.426.559]
Benzene Derivatives [D02.455.426.559.389]
Benzoates [D02.455.426.559.389.127]
Aminobenzoates [D02.455.426.559.389.127.020]
meta-Aminobenzoates [D02.455.426.559.389.127.020.452]
Mesalamine [D02.455.426.559.389.127.020.452.750]
Hydroxybenzoates [D02.455.426.559.389.127.281]
Salicylates [D02.455.426.559.389.127.281.595]
Aminosalicylic Acids [D02.455.426.559.389.127.281.595.100]
Mesalamine [D02.455.426.559.389.127.281.595.100.540]
Phenols [D02.455.426.559.389.657]
Hydroxybenzoates [D02.455.426.559.389.657.410]
Salicylates [D02.455.426.559.389.657.410.595]
Aminosalicylic Acids [D02.455.426.559.389.657.410.595.100]
Mesalamine [D02.455.426.559.389.657.410.595.100.540]

Below are MeSH descriptors whose meaning is related to "Mesalamine".

Below are MeSH descriptors whose meaning is more specific than "Mesalamine".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Mesalamine" by people in UAMS Profiles by year, and whether "Mesalamine" was a major or minor topic of these publications.

Bar chart showing 7 publications over 6 distinct years, with a maximum of 2 publications in 2017

To see the data from this visualization as text, click here.

Below are the most recent publications written about "Mesalamine" by people in Profiles over the past ten years.

Syal G, Barnes E, Raffals L, Al Kazzi E, Haydek J, Agarwal M, Singh S. Medical Therapies for Prevention and Treatment of Inflammatory Pouch Disorders-A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2025 Jan 01; 120(1):135-150.

View in: PubMed
Lupo AM, Lawson AA, Rentea RM, Kapalu CL, Rosen JM. Intravaginal Mesalamine Administration: A Novel Technique for Neovaginal Colitis. J Pediatr Adolesc Gynecol. 2024 Feb; 37(1):93-94.

View in: PubMed
Hyams JS, Davis Thomas S, Gotman N, Haberman Y, Karns R, Schirmer M, Mo A, Mack DR, Boyle B, Griffiths AM, LeLeiko NS, Sauer CG, Keljo DJ, Markowitz J, Baker SS, Rosh J, Baldassano RN, Patel A, Pfefferkorn M, Otley A, Heyman M, Noe J, Oliva-Hemker M, Rufo PA, Strople J, Ziring D, Guthery SL, Sudel B, Benkov K, Wali P, Moulton D, Evans J, Kappelman MD, Marquis MA, Sylvester FA, Collins MH, Venkateswaran S, Dubinsky M, Tangpricha V, Spada KL, Saul B, Wang J, Serrano J, Hommel K, Marigorta UM, Gibson G, Xavier RJ, Kugathasan S, Walters T, Denson LA. Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study. Lancet. 2019 04 27; 393(10182):1708-1720.

View in: PubMed
Hyams JS, Davis S, Mack DR, Boyle B, Griffiths AM, LeLeiko NS, Sauer CG, Keljo DJ, Markowitz J, Baker SS, Rosh J, Baldassano RN, Patel A, Pfefferkorn M, Otley A, Heyman M, Noe J, Oliva-Hemker M, Rufo P, Strople J, Ziring D, Guthery SL, Sudel B, Benkov K, Wali P, Moulton D, Evans J, Kappelman MD, Marquis A, Sylvester FA, Collins MH, Venkateswaran S, Dubinsky M, Tangpricha V, Spada KL, Britt A, Saul B, Gotman N, Wang J, Serrano J, Kugathasan S, Walters T, Denson LA. Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study. Lancet Gastroenterol Hepatol. 2017 12; 2(12):855-868.

View in: PubMed
Heath JL, Heath RD, Tamboli C, Johnson L, Wilson AS, Chervinskiy S, Bell MC, Kennedy JL. Mesalamine desensitization in a patient with treatment refractory ulcerative colitis and aspirin and nonsteroidal anti-inflammatory drug hypersensitivity. Ann Allergy Asthma Immunol. 2017 Apr; 118(4):518-520.

View in: PubMed
Cannon AR, Akhtar S, Hammer AM, Morris NL, Javorski MJ, Li X, Kennedy RH, Gamelli RL, Choudhry MA. Effects of Mesalamine Treatment on Gut Barrier Integrity After Burn Injury. J Burn Care Res. 2016 Sep-Oct; 37(5):283-92.

View in: PubMed

People

See all people

Similar Concepts

Top Journals